Kadans Science Partner, a leading investor in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors, today announced that construction work has started at Merlin Place, North Cambridge.
FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal Hemoglobinuria
The FDA approved iptacopan (Fabhalta) as the first oral monotherapy for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare but potentially fatal disorder affecting red